InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (3 ops.)
Discover the detailed record of transactions filed by Behbahani Ali, Director. Director active across 9 companies, notably Oyster Point Pharma, Inc.. Cumulatively, 24 filings have been logged. Total volume traded: €5m. The latest transaction was disclosed on 17 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations24 total
€11,2605,850 shares@ €1.92470.0081% mcap12.4% of flow
Common Stock
SEC:0001209191-22-037904:0·
€113,00249,792 shares@ €2.26951.75% mcap100.0% of flow
Common Stock
SEC:0001209191-22-036638:0·
03,573 shares0
Common Stock
SEC:0001209191-22-035068:0·
€361,3305,931,843 shares@ €0.0609100.0% of flow
Common Stock
SEC:0001209191-22-032320:0·
€5m2,631,578 shares@ €1.74670.23% mcap100.0% of flow
Common Stock
SEC:0001209191-22-024314:0·
Ideal exit: 6 Jan 2023 (T+270)
€11,8254,346 shares@ €2.72080.0085% mcap13.1% of flow
Common Stock
SEC:0001209191-22-020012:0·
€43,94637,570 shares@ €1.1697100.0% of flow
Common Stock
SEC:0001209191-21-071267·
€43,94637,570 shares@ €1.169750.0% of flow
Common Stock
SEC:0001209191-21-071267:0·
€11,5812,472 shares@ €4.68534.3% of flow
Common Stock
SEC:0001209191-21-070311·
€11,5812,472 shares@ €4.6850.0084% mcap12.8% of flow
Common Stock
SEC:0001209191-21-070311:0·
281 shares
Common Stock
SEC:0001209191-21-061995·
281 shares
Common Stock
SEC:0001209191-21-061995:0·
1,851,852 shares
Common Stock
SEC:0001209191-21-061092·
Ideal exit: 15 Jul 2022 (T+270)
1,851,852 shares
Common Stock
SEC:0001209191-21-061092:0·
Ideal exit: 15 Jul 2022 (T+270)
€11,1561,326 shares@ €8.41333.0% of flow
Common Stock
SEC:0001209191-21-057470·
€11,1561,326 shares@ €8.4130.0081% mcap12.3% of flow
Common Stock
SEC:0001209191-21-057470:0·
5,864,718 shares
Common Stock
SEC:0001209191-21-044189·
2,715,968 shares
Common Stock
SEC:0001209191-21-044037·
2,715,968 shares
Common Stock
SEC:0001209191-21-044037:0·
5,864,718 shares
Common Stock
SEC:0001209191-21-044189:0·
€11,0221,014 shares@ €10.870132.6% of flow
Common Stock
SEC:0001209191-21-042549·
€11,0221,014 shares@ €10.87010.0080% mcap12.2% of flow
Common Stock
SEC:0001209191-21-042549:0·
03,466 shares0
Common Stock
SEC:0001209191-21-039344·
03,466 shares0
Common Stock
SEC:0001209191-21-039344:0·
24 of 24 declarations
About Behbahani Ali
Ali Behbahani is an executive at Oyster Point Pharma, Inc.
